Abstract：
Gliomas are a kind of brain cancer that develops from glial cells. Glial cells provide nourishment and energy to nerve cells, and they also preserve the blood-brain barrier. A primary cancer of the central nervous system (CNS) is oligodendroglioma. This suggests that it originates in the brain or spinal cord. While oligodendrogliomas can strike anyone at any age, the age range of 35 to 44 is when they most commonly occur. Oligodendrogliomas are rare in young people and more common in men than women. Based on anecdotal data, patients with oligodendroglioma may present management challenges in Africa. There are delays in diagnosis and referrals due to the scarcity of neuroimaging facilities. A wide range of strategies have been put forth to improve pathology services in low- and middle-income nations. Adequate mentorship, short-term visitor programs, overcoming supply chain constraints, establishing training standards, and establishing the role of pathologists in cancer screening and early diagnosis have all been proposed as solutions to this problem. To sum up, oligodendroglioma is one of the low-grade gliomas this study looked at. Brain cancer is a serious public health concern in Africa. Improved options for screening and therapy are required to better address this problem.
摘要：
胶质瘤是一种由神经胶质细胞发展而来的脑癌。胶质细胞为神经细胞提供营养和能量，它们还能保护血脑屏障。中枢神经系统（CNS）的原发性癌症是少突胶质细胞瘤。这表明它起源于大脑或脊髓。少突神经胶质瘤可以袭击任何年龄的人，35至44岁是最常见的年龄。少突神经胶质瘤在年轻人中很少见，在男性中比女性更常见。根据轶事数据，少突胶质细胞瘤患者在非洲可能面临治疗挑战.由于神经影像学设施的短缺，诊断和转诊存在延迟。已经提出了广泛的策略来改善低收入和中等收入国家的病理学服务。充分的指导,短期访客计划，克服供应链约束，建立培训标准，以及建立病理学家在癌症筛查和早期诊断中的作用都被提出作为解决这一问题的方法。总而言之,少突胶质细胞瘤是本研究观察的低度胶质瘤之一。脑癌是非洲严重的公共卫生问题。需要改进的筛选和治疗选择以更好地解决该问题。
